Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

YOU MIGHT BE INTERESTED IN

  1. Medical Devices: Industry and Market Prospects 2010-2025

    Medical Devices: Industry and Market Prospects 2010-2025

    How will the medical devices sector develop from 2010, and where can you find opportunities? We show you prospects for technological development and revenue growth. You can have our new report today, staying ahead.

    ...more details
  2. Translational Regenerative Medicine: Market Prospects 2011-2021

    Translational Regenerative Medicine: Market Prospects 2011-2021

    What are the commercial prospects for regenerative medicine? Our new report shows you potential revenues to 2021, discussing opportunities and market prospects. Our study identifies three main areas: tissue engineering, stem cell therapy and gene therapy.

    ...more details
  3. Stem Cell Technologies: World Market Outlook 2011-2021

    Stem Cell Technologies: World Market Outlook 2011-2021

    How will the stem cells market develop this decade? Our new report shows you that emerging industry and market's revenue potential from 2011 to 2021. This report covers stem cells in therapeutic applications: technologies, products and services. You will assess events, opportunities and activities shaping that industry. Our new study shows you revenue prospects for stem cells at total world, submarket and product levels to 2021. What activities will expand that market from 2011 to 2021?

    ...more details
  4. World Diabetes Drug Market 2011-2021

    World Diabetes Drug Market 2011-2021

    Where will revenue growth occur in the diabetes treatment market? Our new report shows you the potential that drug market offers from 2011 to 2021, explaining the opportunities there. You will discover revenue prospects for diabetes treatments at total world, sub-market, product and national levels. We show potential revenues for human insulins and analogues, as well as other diabetes treatments. You will discover revenue prospects for Novo Nordisk, GSK, Takeda, sanofi-aventis, Eli Lilly, Merck and other companies from 2011 onwards.

    ...more details
  5. Companion Diagnostics: World Market Outlook 2011-2021

    Companion Diagnostics: World Market Outlook 2011-2021

    Our latest pharma report - Companion Diagnostics: World Market Outlook 2011-2021 - offers a comprehensive view of the global companion diagnostics market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the companion diagnostics market in 2011 to be worth $1.57bn. A number of specialty drugs will be associated with a companion diagnostic test by 2021, increasing the global market for companion diagnostics.

    ...more details

PHARMA REPORT

rss_Pharma.jpg...see all
Advanced Wound Care: World Market Prospects 2011-2021

Advanced Wound Care: World Market Prospects 2011-2021

  • Publication date: 11/11/2011
  • Number of Pages: 157
  1. Report Details
  2. Table of Contents
  3. Companies Listed

Report Details

The wound care devices and biologics segment within the advanced wound care market are set for rapid growth over the next ten years. The growth in the market will be driven primarily by the increasing prevalence of diabetes and obesity, coupled with the aging population, which will increase the incidence of chronic wounds. The adoption of expensive but more effective wound care devices and biologics will increase in the developed countries in the near future. Visiongain calculates the total advanced wound care market to be worth $6.7bn in 2011.

Our latest pharma report - Advanced Wound Care: World Market Prospects, 2011-2021 - examines the global advanced wound care market over the next decade, providing detailed market forecasts for three main segments of the market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report offers in-depth analysis of the opportunities and challenges facing companies in the market throughout the world. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market.

The Advanced Wound Care: World Market Prospects, 2011-2021 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size, leading companies and products, and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2021, primarily driven by a rise in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products.

How will the advanced wound care market develop this decade? Which regions offer the most significant growth opportunities between 2011 and 2021? Which of the advanced wound care submarkets are growing most strongly? Who are the leading companies in the advanced wound care market? What are the most promising products in development and when are they expected to receive market approval? Visiongain answers these critical questions and many more through the in-depth analyses that are presented in this report.

Detailed analysis of the global Advanced Wound Care Market

Advanced Wound Care: World Market Prospects, 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including SWOT analysis. There are 114 tables and figures included, as well as two full interviews with relevant authorities. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Advanced Wound Care: World Market Prospects, 2011-2021

In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for advanced wound care, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall advanced wound care market from 2011 to 2021 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - moist wound care, wound care devices, and wound care biologics - from 2011 to 2021, with detailed discussions of market potential
• You will receive sales forecasts for leading geographical markets (US, Japan, Germany, France, Italy, Spain, UK, China and India), with informed discussion
• You will assess leading companies in the advanced wound care market along with their marketed and pipeline products
• You will receive our analyses of the future of advanced wound care market, including assessment of some products in the R&D pipeline
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the advanced wound care segment from 2011 onwards
• You will be able to investigate competition and opportunities influencing the advanced wound care market from 2011 onwards
• You will see what will stimulate and restrain the advanced wound care market from 2011
• You will discover the unmet needs in the market, driving the growth from 2011 onwards
• You will view expert opinion from our survey, including full interview transcripts.

You can order this report today

Anybody with an interest in the advanced wound care market should gain valuable information and insight from this new study by Visiongain, which analyses one of the most important exciting market in the wound care industry. This visiongain pharma report will be valuable both to those already involved in the advanced wound care market and those wishing to enter the market in the future. Gain an understanding of how to tap into the potential of this market by ordering Advanced Wound Care: World Market Prospects, 2011-2021.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

Table of Contents

1. Executive Summary
1.1 Advanced Wound Care: Market Review
1.2 Overview of Chapter Content
1.3 Research and Analysis Method
1.4 Glossary of Terms Relating to Advanced Wound Care

2. Introduction
2.1 What is a Wound?
2.1.1 Wound Classification
2.1.1.1 Acute Wounds
2.1.1.2 Chronic Wounds
2.1.1.2.1 The Increasing Prevalence of Chronic Wounds
2.1.1.3 Burns
2.2 The Skin
2.2.1 The Phases of Wound Healing
2.2.1.1 The Inflammatory Phase
2.2.1.2 The Proliferation Phase
2.2.1.3 The Fibroblastic Phase
2.2.1.4 The Maturation Phase
2.3 Wound Care
2.3.1 The Functions of Wound Care
2.3.2 The History of Wound Care
2.4 Wound Care Categories
2.4.1 Traditional Wound Care
2.4.2 Advanced Wound Care (AWC)
2.4.2.1 Moist Wound Care (MWC)
2.4.2.1.1 Alginate Dressings
2.4.2.1.2 Foam Dressings
2.4.2.1.3 Hydrocolloid Dressings
2.4.2.1.4 Hydrogel Dressings
2.4.2.2 Wound Care Devices
2.4.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.4.2.2.2 Ultrasound for Wound Therapy
2.4.2.2.3 Electrical Stimulation
2.4.2.3 Biologics
2.4.2.3.1 Skin Replacement Therapies
2.4.2.3.2 Collagen Based Therapies
2.4.2.3.3 Cell Therapies
2.5 Regulation of Advanced Wound Care
2.5.1 The US Approval and Regulation System
2.5.2 The European Approval and Regulation Process

3. The Global Advanced Wound Care Market, 2010-2021
3.1 Advanced Wound Care: Market Overview
3.1.1 The Size of the Advanced Wound Care Market in 2010
3.2 Regional Market Breakdown, 2010
3.2.1 The US, European and Japanese Markets, 2010
3.2.2 The Chinese and Indian Market, 2010
3.3 Global Advanced Wound Care Market Forecast, 2011-2015
3.4 Global Advanced Wound Care Market Forecast, 2015-2021
3.5 Leading National Markets for Advanced Wound Care: Sales Forecasts, 2011-2021
3.5.1 The US, European and Japanese Markets, 2011-2021
3.5.1.1 The US Market
3.5.1.2 The European Market
3.5.1.3 The Japanese Market
3.5.2 The Chinese and Indian Markets, 2011-2021
3.5.2.1 The Chinese Market
3.5.2.2 The Indian Market

4. The Moist Wound Care Market, 2010-2021
4.1 The Moist Wound Care Market: Overview
4.1.1 The Moist Wound Care Market, 2010
4.1.2 Moist Wound Care Market Forecast, 2011-2021
4.2 The Moist Wound Care Market Segments, 2011-2021
4.2.1 The Hydrocolloid Dressings Market
4.2.2 The Foam Dressings Market
4.2.3 The Alginate Dressings Market
4.2.4 The Hydrogel Dressings Market
4.2.5 Other MWC Dressings Market
4.2.5.1 Hydrofiber Technology (ConvaTec)
4.3 The Moist Wound Care Pipeline
4.3.1 NanoDOX (Nanotherapeutics)
4.3.2 Novel Antimicrobial Silver Dressing (AGT Sciences Ltd)
4.3.3 '1' Primary Wound Dressing (Phytoceuticals)
4.4 SWOT Analysis of the Moist Wound Care Market, 2011-2021
4.4.1 Strengths
4.4.1.1 Established Segment of the Market
4.4.1.2 Wide Variety of Products
4.4.1.3 More Effective than Traditional Wound Care
4.4.2 Weaknesses
4.4.2.1 Less Effective than Some Devices and Biologics
4.4.2.2 Weak R&D Pipeline
4.4.3 Opportunities
4.4.3.1 Increasing Prevalence of Chronic Wounds
4.4.3.2 Cheap Alternative to Devices and Biologics
4.4.4 Threats
4.4.4.1 Emerging Technologies May be More Effective
4.4.4.2 Lack of R&D Spending Will Stifle Innovation

5. Wound Care Devices Market, 2010-2021
5.1 Wound Care Devices Market: Overview
5.1.1 The Wound Care Devices Market in 2010: Segment and Regional Breakdown
5.1.2 The Wound Care Devices Forecast, 2011-2021
5.2 The NPWT Market
5.2.1 The NPWT Market in 2010
5.2.2 Leading NPWT Devices: Product Analysis
5.2.2.1 V.A.C. Therapy (KCI)
5.2.2.1.1 V.A.C. Via (Kinetic Concepts Inc)
5.2.2.2 RENASYS Systems (Smith & Nephew)
5.2.2.3 Other NPWT Systems
5.2.2.3.1 POSiFECT (Biofisica)
5.3 The NPWT Market Forecast, 2011-2015
5.4 The NPWT Market Forecast, 2015-2021
5.5 The Wound Care Devices Pipeline
5.5.1 dermaPACE (Sanuwave Health)
5.5.2 O-ACE-Sys (Ingenious Technologies Corporation)
5.5.3 Red Light Wave Therapy (Lightwave Technologies)
5.5.4 MIST Therapy (Celleration)
5.6 SWOT Analysis of the Wound Care Devices Market, 2011-2021
5.6.1 Strengths
5.6.1.1 More Effective than Other Forms of Wound Care
5.6.1.2 Constant Innovation in the Market
5.6.2 Weaknesses
5.6.2.1 Dominated by Few Large Companies
5.6.2.2 NPWT Dominates the Market
5.6.3 Opportunities
5.6.3.1 Low Cost NPWT Systems will Drive Growth
5.6.3.2 Increasing Prevalence of Chronic Wounds
5.6.4 Threats
5.6.4.1 Controversy Regarding Safety of NPWT
5.6.4.2 Ongoing Legal Battles Threaten Innovation

6. The Wound Care Biologics Market, 2010-2021
6.1 Wound Care Biologics Market: Overview
6.1.1 Wound Care Biologics Market in 2010: Market Segments and Regional Breakdown
6.1.2 The Wound Care Biologics Market Forecast, 2011-2021
6.2 The Skin Replacement Market
6.2.1 The Skin Replacement Market in 2010
6.2.2 Leading Products in the Skin Replacement Market, 2010
6.2.2.1 Dermagraft (Advanced BioHealing, a Division of Shire Pharmaceuticals)
6.2.2.2 Apligraf (Organogenesis)
6.2.2.3 Other Leading Products
6.2.3 The Skin Replacement Market Forecast, 2011-2015
6.2.4 The Skin Replacement Market Forecast, 2015-2021
6.3 Collagen Based Therapy
6.3.1 Collagen Based Therapy Market in 2010
6.3.2 The Collagen Based Therapy Market Forecast, 2011-2015
6.3.3 The Collagen Based Therapy Market Forecast, 2015-2021
6.4 The Cell Therapy Market
6.4.1 The Cell Therapy Market in 2010
6.4.2 Leading Products in the Cell Therapy Market, 2010
6.4.3 The Cell Therapy Market Forecast, 2011-2015
6.4.4 The Cell Therapy Market Forecast, 2015-2021
6.5 The Biologics Pipeline
6.5.1 Stem Cells
6.5.1.1 Stem Cell Skin Gun (McGowan Institute for Regenerative Medicine at the University of Pittsburgh)
6.5.1.2 Adult Stem Cells (Cryo-Cell International and The Snyder Wound Research Institute)
6.5.1.3 Mesenchymal Stem Cells (Nara University, Japan)
6.5.2 Artificial Skin
6.5.2.1 e-Skin (UC Berkeley)
6.5.2.2 Genetically Modified Artificial Skin (University of Cincinnati)
6.5.3 Cell Therapy
6.5.3.1 ReCell (Avita Medical)
6.5.4 Automated Artificial Skin Production
6.5.4.1 The Tissue Factory (Fraunhofer Institute)
6.5.5 Nanotechnology
6.5.5.1 DermaFuse (Missouri S&T and Mo-Sci Corporation)
6.5.5.2 Phytochemical Tissue Bonding (Harvard University Institute of Photomedicine)
6.5.5.3 Giant Unilamellar Vesicles (University of Bath)
6.5.6 Collagen Based Therapy
6.5.6.1 Artificial Collagen Based Wound Care (Cornell University)
6.5.7 Diagnostic Tests
6.5.7.1 WOUNDCHEK (Systagenix Wound Management)
6.6 SWOT Analysis of the Wound Care Biologics Market, 2011-2021
6.6.1 Strengths
6.6.1.1 More Effective Than Other Forms of Wound Care
6.6.1.2 New Technology with Constant Innovation
6.6.1.3 Strong R&D Pipeline
6.6.2 Weaknesses
6.6.2.1 Small Start-up Companies Dominate the Market
6.6.2.2 Expensive Technology
6.6.2.3 High Barriers to Entry
6.6.3 Opportunities
6.6.3.1 Strong Innovation Will Drive Growth
6.6.3.2 Stem Cells Offer Multiple Opportunities
6.6.3.3 Increasing Prevalence of Chronic Wounds
6.6.4 Threats
6.6.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.6.4.2 High Barriers to Entry will Deter Competitors
6.6.4.3 Competition from MWC and Devices

7. Advanced Wound Care Market: Analysis by Company, 2010
7.1 Smith & Nephew (S&N)
7.1.1 Smith & Nephew Advanced Wound Care Sales, 2010
7.1.2 Smith & Nephew Pipeline
7.2 Kinetic Concepts Inc (KCI)
7.2.1 KCI Advanced Wound Care Sales, 2010
7.2.2 KCI Pipeline
7.2.3 The Sale of KCI
7.3 ConvaTec
7.3.1 ConvaTec Sales, 2010
7.3.2 ConvaTec Advanced Wound Care Sales, 2010
7.3.3 ConvaTec Pipeline
7.4 Coloplast
7.4.1 Coloplast Sales, 2010
7.4.2 Coloplast Advanced Wound Care Sales, 2009/2010
7.5 Systagenix Wound Management
7.5.1 Systagenix Pipeline

8. Expert Opinions
8.1 Dr Edward Lin, CEO & Founder of Ingenious Technologies Corporation
8.1.1 The Wound Care Market
8.1.2 O-ACE-Sys Device Being Developed by Dr Lin
8.1.3 NPWT Devices
8.1.4 The Future of Wound Care Devices
8.2 Professor Kiminobu Sugaya, Professor of Neuroscience, Burnett School of Biomedical Science, University of Central Florida
8.2.1 The Current Stem Cell Field
8.2.2 Public Perception of Stem Cell Research
8.2.3 iPS cells and Wound Healing

9. Conclusions
9.1 The Advanced Wound Care Market, 2010-2021
9.1.1 Growth will be Driven by an Increasing Prevalence of Chronic Wounds
9.1.2 Emerging Markets will Drive Growth
9.2 The Moist Wound Care Market
9.3 The Wound Care Devices Market
9.4 The Wound Care Biologics Market

Appendix A
Appendix B - Visiongain report evaluation form

List of Tables
Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Wound Care Market ($bn) by Sectors, 2010
Table 2.5 The Advantages and Disadvantages of Moist Wound Care
Table 2.6 The Benefits and Risks of Skin Grafting
Table 3.1 The Advanced Wound Care Market ($bn) by Segments, 2010
Table 3.2 Leading National Markets for Advanced Wound Care ($bn), 2010
Table 3.3 Global Advanced Wound Care Market Forecast ($bn), 2010-2015
Table 3.4 Global Advanced Wound Care Market Forecast ($bn), 2015-2021
Table 3.5 Leading Advanced Wound Care National Market Forecasts ($bn), 2010-2015
Table 3.6 Leading Advanced Wound Care National Market Forecasts ($bn), 2015-2021
Table 3.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2011-2021
Table 4.1 The Moist Wound Care Market ($bn) by Segments, 2010
Table 4.2 The Moist Wound Care Market ($bn) by Country/Region, 2010
Table 4.3 The Moist Wound Care Market Forecast ($bn), 2010-2015
Table 4.4 The Moist Wound Care Market Forecast ($bn), 2015-2021
Table 4.5 Moist Wound Care Products Pipeline, 2011
Table 4.6 SWOT Analysis of the Moist Wound Care Market, 2011-2021
Table 5.1 The Wound Care Device Market ($bn) by Segments, 2010
Table 5.2 The Wound Care Devices Market ($bn) by Country/Region, 2010
Table 5.3 The Wound Care Devices Market Forecast ($bn), 2010-2015
Table 5.4 The Wound Care Devices Market Forecast ($bn), 2015-2021
Table 5.5 Leading Products in the NPWT Market: Sales ($bn) and Market Share (%), 2010
Table 5.6 The NPWT Market Forecast ($bn), 2010-2015
Table 5.7 The NPWT Market Forecast ($bn), 2015-2021
Table 5.8 Drivers and Restraints in the NPWT Market, 2010-2021
Table 5.9 Wound Care Devices Development Pipeline, 2011
Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2011-2021
Table 6.1 The Wound Care Biologics Market ($m) by Segments, 2010
Table 6.2 The Wound Care Biologics Market ($m) by Country/Region, 2010
Table 6.3 The Wound Care Biologics Market Forecast ($bn), 2010-2015
Table 6.4 The Wound Care Biologics Market Forecast ($bn), 2015-2021
Table 6.5 Drivers and Restraints in the Biologics Market, 2011-2021
Table 6.6 Dermagraft Sales ($m) 2007-2010
Table 6.7 Other Leading Products in the Skin Replacement Market, 2010
Table 6.8 The Skin Replacement Market Forecast ($bn), 2010-2015
Table 6.9 The Skin Replacement Market Forecast ($bn), 2015-2021
Table 6.10 Leading Products in the Collagen Based Therapy Market, 2010
Table 6.11 The Collagen Based Therapy Market Forecast ($bn), 2010-2015
Table 6.12 The Collagen Based Therapy Market Forecast ($bn), 2015-2021
Table 6.13 Leading Products in the Cell Therapy Market, 2010
Table 6.14 The Cell Therapy Market Forecast ($m), 2010-2015
Table 6.15 The Cell Therapy Market Forecast ($m), 2015-2021
Table 6.16 The Wound Care Biologics Development Pipeline, 2011
Table 6.17 SWOT Analysis of the Wound Care Biologics Market, 2011-2021
Table 7.1 Smith & Nephew Sales ($m) by Business Segments, 2010
Table 7.2 Smith & Nephew Sales ($m) by Region, 2010
Table 7.3 Smith & Nephew Advanced Wound Management Sales ($m) by Region, 2010
Table 7.4 KCI Total Revenue ($m) by Sales and Rentals, 2010
Table 7.5 KCI Total Sales ($m) by Business Segments, 2010
Table 7.6 KCI Active Healing Solutions (AHS) Sales ($m) by Region, 2010
Table 7.7 ConvaTec Sales ($m) by Business Segments, 2010
Table 7.8 ConvaTec Sales ($m) by Region, 2010
Table 7.9 Coloplast Sales ($bn) by Business Segments, 2009/2010
Table 7.10 Coloplast Sales ($bn) by Region, 2009/2010
Table 9.1 Global Advanced Wound Care Market: Drivers and Restraints, 2011-2021

List of Figures
Figure 2.1 The Phases of Wound Healing and Duration (Days)
Figure 2.2 Market Shares (%) of the Leading Sectors in the Wound Care Market, 2010
Figure 3.1 The Advanced Wound Care Market Share (%) by Segments, 2010
Figure 3.2 The Advanced Wound Care Market ($bn) by Segments, 2010
Figure 3.3 The Advanced Wound Care Market Share (%) in Leading National Markets, 2010
Figure 3.4 The Advanced Wound Care Market ($bn) in Leading National Markets, 2010
Figure 3.5 Global Advanced Wound Care Market Forecast ($bn), 2010-2015
Figure 3.6 Global Advanced Wound Care Market Forecast ($bn), 2015-2021
Figure 3.7 The US Advanced Wound Care Market Forecast ($bn), 2010-2015
Figure 3.8 The European Advanced Wound Care Market Forecast ($bn), 2010-2015
Figure 3.9 The Asian Advanced Wound Care Market Forecasts ($bn), 2010-2015
Figure 3.10 The US Advanced Wound Care Market Forecast ($bn), 2015-2021
Figure 3.11 The European Advanced Wound Care Market Forecast ($bn), 2015-2021
Figure 3.12 The Asian Advanced Wound Care Market Forecasts ($bn), 2015-2021
Figure 4.1 The Moist Wound Care Market Share (%) by Segments, 2010
Figure 4.2 The Moist Wound Care Market ($bn) by Segments, 2010
Figure 4.3 Moist Wound Care Market Shares (%) by Country/Region, 2010
Figure 4.4 Total Moist Wound Care Market Forecast ($bn), 2010-2015
Figure 4.5 Total Moist Wound Care Market Forecast ($bn), 2015-2021
Figure 5.1 The Wound Care Devices Market Share (%) by Segments, 2010
Figure 5.2 The Wound Care Devices Market ($bn) by Segments, 2010
Figure 5.3 The Wound Care Devices Market Share (%) by Country/Region, 2010
Figure 5.4 The Wound Care Devices Market Sales ($bn) by Country/Region, 2010
Figure 5.5 Total Wound Care Devices Market Forecast ($bn), 2010-2015
Figure 5.6 NPWT and Ultrasound Wound Therapy Devices Market Forecasts ($bn), 2010-2015
Figure 5.7 Total Wound Care Devices Market Forecast ($bn), 2015-2021
Figure 5.8 NPWT and Ultrasound Wound Therapy Devices Market Forecasts ($bn), 2015-2021
Figure 5.9 The NPWT Devices Market Share (%) by Leading Products, 2010
Figure 5.10 The NPWT Market Forecast ($bn), 2010-2015
Figure 5.11 The NPWT Market Forecast ($bn), 2015-2021
Figure 6.1 The Wound Care Biologics Market Share (%) by Segments, 2010
Figure 6.2 The Wound Care Biologics Market ($m) by Segments, 2010
Figure 6.3 The Wound Care Biologics Market Share (%) by Country/Region, 2010
Figure 6.4 The Wound Care Biologics Market Sales ($m) by Country/Region, 2010
Figure 6.5 The Biologics Market Forecast ($bn), 2010-2021
Figure 6.6 Dermagraft Sales ($m) 2007-2010
Figure 6.7 The Skin Replacement Market Forecast ($bn), 2010-2015
Figure 6.8 The Skin Replacement Market Forecast ($bn), 2015-2021
Figure 6.9 The Collagen Based Therapy Market Forecast ($bn), 2010-2015
Figure 6.10 The Collagen Based Therapy Market Forecast ($bn), 2015-2021
Figure 6.11 The Cell Therapy Market Forecast ($m), 2010-2015
Figure 6.12 The Cell Therapy Market Forecast ($bn), 2015-2021
Figure 7.1 Smith & Nephew Sales Share (%) by Business Segment, 2010
Figure 7.2 Smith & Nephew Sales ($m) by Business Segment, 2010
Figure 7.3 Smith & Nephew Sales Share (%) by Region, 2010
Figure 7.4 Smith & Nephew Sales ($m) by Region, 2010
Figure 7.5 Smith & Nephew Advanced Wound Management Sales Share (%) by Region, 2010
Figure 7.6 KCI Total Revenue Shares (%) by Sales and Rentals, 2010
Figure 7.7 KCI Total Sales Share (%) by Business Segments, 2010
Figure 7.8 KCI Total Sales ($m) by Business Segments, 2010
Figure 7.9 KCI Active Healing Solutions (AHS) Sales Share (%) by Region, 2010
Figure 7.10 ConvaTec Sales Share (%) by Business Segment, 2010
Figure 7.11 ConvaTec Sales ($m) by Business Segment, 2010
Figure 7.12 ConvaTec Sales Share (%) by Region, 2010
Figure 7.13 Coloplast Sales Share (%) by Business Segments, 2009/2010
Figure 7.14 Coloplast Sales ($bn) by Business Segments, 2009/2010
Figure 7.15 Coloplast Sales Share (%) by Region, 2009/2010 

Companies Listed

3M
ACell
Advanced BioHealing
Advanced Medical Solutions Group
AGT Sciences Ltd
Apax Partners
Avista Capital partners
Avita Medical
Biofisica
Biolight AB
Blackstone Group
BlueSky Medical
Boehringer Wound Systems LLC
Brennen Medical
Bristol-Myers Squibb
Celleration
Center for Biologics Evaluation and Research
Centres for Medicare & Medicaid Services (CMS)
ConvaTec
Cornell University
Covidien
Cryo-Cell International
Derma Sciences
Dr. Suwelack Skin & Health Care
E.R Squibb & Sons
Fidia
Genadyne Biotechnologies
Genzyme
Genzyme Biosurgery
Food & Drug Administration (FDA)
Forticell Bioscience
Harvard University Institute of Photomedicine
HealO Medical
HealthPoint
Ingenious Technologies Corporation
Innovative Therapies Inc
Integra Life Sciences
Japanese Ministry of Health, Labour and Welfare (MHLW)
Johnson & Johnson
Kalypto Medical
Kinetic Concepts Inc (KCI)
Lescarden
LifeCell
Lightwave Technologies
MacroCure
Massachusetts Institute of Technology (MIT)
McGowan Institute for Regenerative Medicine at the University of Pittsburgh
MCS Med
Medela Inc
Medestea Internazionale
Medline Industries
Missouri S&T
Mo-Sci Corporation
Molnlycke
Nanotherapeutics
Nara University, Japan
Nordic Capital Partners
Novartis
Office of Combination Products
Ogenix Corporation
One Equity Partners
Ortec International
Osiris Therapeutics
Pfizer
Phytoceuticals
Polyheal
Progenicyte
Prospera
Sanuwave Health Inc
Smith & Nephew
Snyder Wound Research Institute
Spiracur
Systagenix
Talley Group
The Fraunhofer Institute for Interfacial Engineering and Biotechnology
UC Berkeley
UDL Laboratories
UK Healthcare Industry Task Force
University Hospital Bern, Switzerland
University of Bath
University of Chicago
University of Cincinnati
US Armed Forces Institute of Regenerative Medicine
Wound Management Technologies
Wright Medical 

 

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close